Skip navigation
Skip navigation

Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study

McNeil, John J; Woods, Robyn; Nelson, Mark; Murray, Anne M.; Reid, Christopher M; Kirpach, Brenda; Storey, Elsdon; Shah, Raj C.; Wolfe, Rory; Tonkin, Andrew; Abhayaratna, Walter


Background There are no primary prevention trials of aspirin with relevant geriatric outcomes in elderly people. ASPirin in Reducing Events in the Elderly (ASPREE) is a placebo-controlled trial of low-dose aspirin that will determine whether 5 years of daily 100-mg enteric-coated aspirin extends disability-free and dementia-free life in a healthy elderly population and whether these benefits outweigh the risks. Methods Set in primary care, this randomized double-blind placebo-controlled...[Show more]

CollectionsANU Research Publications
Date published: 2017
Type: Journal article
Source: Journals of Gerontology Series A: Biological Sciences and Medical Sciences
DOI: 10.1093/gerona/glw342


There are no files associated with this item.

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator